No abstract available
MeSH terms
-
Aniline Compounds / therapeutic use
-
Antineoplastic Agents / adverse effects*
-
Antineoplastic Agents / therapeutic use
-
Contraindications, Drug
-
Cross-Sectional Studies
-
Drug Substitution
-
Endothelium, Vascular / drug effects
-
Endothelium, Vascular / metabolism
-
Endothelium, Vascular / pathology
-
Humans
-
Interleukin-1beta / blood*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Male
-
Middle Aged
-
Myocardial Infarction / chemically induced
-
Myocardial Infarction / etiology*
-
Myocytes, Cardiac / drug effects
-
Myocytes, Cardiac / metabolism
-
Myocytes, Cardiac / pathology
-
Nitriles / therapeutic use
-
Protein Kinase Inhibitors / adverse effects*
-
Protein Kinase Inhibitors / pharmacology
-
Protein Kinase Inhibitors / therapeutic use
-
Pyrimidines / adverse effects*
-
Pyrimidines / pharmacology
-
Pyrimidines / therapeutic use
-
Quinolines / therapeutic use
-
Risk Factors
Substances
-
Aniline Compounds
-
Antineoplastic Agents
-
Interleukin-1beta
-
Nitriles
-
Protein Kinase Inhibitors
-
Pyrimidines
-
Quinolines
-
bosutinib
-
nilotinib